Skip to content

QLB After Nephrectomy

Effectiveness of Quadratus Lumborum Block After Nephrectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03529201
Enrollment
105
Registered
2018-05-18
Start date
2018-05-07
Completion date
2019-08-25
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative, Chronic Postoperative Pain

Brief summary

Oxycodone consumption and postoperative pain intensity in patients undergoing nephrectomy procedures. Of all study participants, 50% will obtain quadratus lumborum block (QLB).

Detailed description

Patients undergoing nephrectomy procedures will be allocated to one of the study arms. At the end of an operation, still under general anesthesia, 50% patients will obtain QLB with ropivacaine. Ultrasound-guided QLB will be performed on the side of surgery with 0.375% ropivacaine solution (0.2 mL per kg). Every patient will get patient-controlled analgesia pump with oxycodone in the postoperative period. Postoperative pain will be measured with VAS (visual-analogue scale) 2, 4, 8, 12 and 24 hours after the end of the operation. 24 -hours period. At the 1, 3, 6 months patients will be interviewed by phone to assess neuropathic pain. Neuropathic Pain Symptom Inventory (NPSI) will be used.

Interventions

PROCEDUREQLB

On the side of the surgery, QLB with 0.375% ropivacaine (0.2 mL/kg)

DEVICEPCA

Patient-controlled analgesia

PROCEDUREGA

General anesthesia

DRUGOxycodone

administered by PCA

DRUGSevoflurane

Inhalational anesthetic during GA

DRUGFentanyl

painkiller during GA

DRUGRocuronium

muscle relaxant during GA

Sponsors

Department of Anesthesiology and Intensive Care, F. Chopin Hospital in Rzeszów
CollaboratorUNKNOWN
Department of Anesthesiology and Intensive Care, J. Śniadecki Hospital in Białystok
CollaboratorUNKNOWN
Medical University of Lublin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

A regional block will be performed under general anesthesia. Patients will not be aware of this procedure.

Intervention model description

Patients will be randomly allocated to one of the study arms: QLB or control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* obtained consent * nephrectomy procedure

Exclusion criteria

* coagulopathy allergy to local anesthetics depression, antidepressant drugs treatment epilepsy usage of painkiller before surgery addiction to alcohol or recreational drugs

Design outcomes

Primary

MeasureTime frameDescription
Total consumption of oxycodone24 hours after the end of surgery.Overall use of oxycodone administered by PCA pump will be assessed.

Secondary

MeasureTime frameDescription
Pain intensity24 hours after the end of surgeryPain intensity measured on VAS scale at the 2, 4, 8, 12, 24 hours. VAS in milimmeters. Minimum value 0, maximum 100. Less better - less severe pain. 0 no pain at all.
Chronic pain6 months after the surgeryChronic pain occurrence assessed with Neuropathic Pain Symptom Inventory (NPSI) 10 descriptive variables, each one from 0 to 10. 0 means no pain. 10 very high chance of occurrence of neuropathic pain.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026